| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Incyte Corporation | COM | 45337C102 | $2,061,155,515 | 36,179,665 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $1,652,869,802 | 10,568,897 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $792,566,676 | 42,864,612 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $526,014,858 | 1,969,798 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $277,241,155 | 6,398,365 | SOLE | |||
| Revolution Medicines, Inc. | COM | 76155X100 | $243,312,295 | 7,549,249 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $241,036,306 | 5,995,928 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $124,691,149 | 27,525,640 | SOLE | |||
| Bicycle Therapeutics plc | SPONSORED ADS | 88786108 | $123,076,293 | 4,942,823 | SOLE | |||
| Edgewise Therapeutics, Inc. | COM | 28036F105 | $106,522,676 | 5,840,059 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $98,495,670 | 1,515,318 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $91,053,177 | 17,310,490 | SOLE | |||
| Roivant Sciences Ltd. | SHS | G76279101 | $78,141,810 | 7,413,834 | SOLE | |||
| Replimune Group, Inc. | COM | 76029N106 | $77,985,395 | 9,545,336 | SOLE | |||
| Denali Therapeutics Inc. | COM | 24823R105 | $76,574,381 | 3,731,695 | SOLE | |||
| Entrada Therapeutics, Inc. | COM | 29384C108 | $68,948,655 | 4,865,819 | SOLE | |||
| Akero Therapeutics, Inc. | COM | 00973Y108 | $68,535,558 | 2,713,205 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $68,473,079 | 1,466,547 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $67,720,113 | 6,443,398 | SOLE | |||
| Cerevel Therapeutics Holdings, Inc. | COM | 15678U128 | $67,632,000 | 1,600,000 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $59,536,370 | 151,215 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $57,067,238 | 3,882,125 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $55,432,954 | 2,809,577 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $51,440,974 | 10,126,176 | SOLE | |||
| Aerovate Therapeutics, Inc. | COM | 8064107 | $49,692,888 | 1,680,517 | SOLE | |||
| Sera Prognostics, Inc. | CLASS A COM | 81749D107 | $49,453,031 | 5,434,399 | SOLE | |||
| Prelude Therapeutics Inc. | COM | 74065P101 | $47,986,926 | 10,123,824 | SOLE | |||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | $46,605,957 | 1,062,123 | SOLE | |||
| Stoke Therapeutics, Inc. | COM | 86150R107 | $45,473,981 | 3,368,443 | SOLE | |||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | $42,777,881 | 993,679 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $39,452,307 | 4,088,322 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $36,812,171 | 19,477,339 | SOLE | |||
| Monte Rosa Therapeutics, Inc. | COM | 61225M102 | $34,658,470 | 4,916,095 | SOLE | |||
| Celcuity Inc. | COM | 15102K100 | $33,533,525 | 1,552,478 | SOLE | |||
| Biomea Fusion, Inc. | COM | 09077A106 | $31,528,788 | 2,108,949 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $30,236,357 | 169,934 | SOLE | |||
| Sana Biotechnology, Inc. | COM | 799566104 | $23,809,490 | 2,380,949 | SOLE | |||
| Neurogene Inc. | COM | 64135M105 | $23,211,164 | 456,015 | SOLE | |||
| Verve Therapeutics, Inc. | COM | 92539P101 | $22,463,518 | 1,691,530 | SOLE | |||
| TScan Therapeutics, Inc. | COM | 89854M101 | $22,111,248 | 2,784,792 | SOLE | |||
| Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | $17,043,495 | 10,787,022 | SOLE | |||
| Immunovant, Inc. | COM | 45258J102 | $13,732,041 | 425,009 | SOLE | |||
| 2seventy bio, Inc. | COMMON STOCK | 901384107 | $13,361,764 | 2,497,526 | SOLE | |||
| Fate Therapeutics, Inc. | COM | 31189P102 | $13,345,449 | 1,818,181 | SOLE | |||
| Xencor, Inc. | COM | 98401F105 | $12,070,388 | 545,431 | SOLE | |||
| Taysha Gene Therapies, Inc. | COM SHS | 877619106 | $11,493,650 | 4,004,756 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $10,947,545 | 14,614,264 | SOLE | |||
| Celldex Therapeutics, Inc. | COM | 15117B202 | $10,393,619 | 247,644 | SOLE | |||
| Relay Therapeutics, Inc. | COM | 75943R102 | $9,628,971 | 1,160,117 | SOLE | |||
| Insmed Incorporated | COM PAR $.01 | 457669307 | $9,305,590 | 343,000 | SOLE |